
Fifty-three patients were selected who underwent SRS and had a contrast-enhanced T1 sequence planning MRI scan and a follow-up contrast enhanced T1 MRI available for review. Median follow-up of 6.5 months (interquartile range/IQR, 5.9–7.4). Median pretreatment tumor volume was 1,006 mm3 (IQR, 465–1,794).
Like
Save
Share